Richard W. Pascoe
2020 - Conatus Pharmaceuticals
In 2020, Richard W. Pascoe earned a total compensation of $540K as President, Chief Executive Officer Director at Conatus Pharmaceuticals, a 74% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $90,000 |
|---|---|
| Salary | $450,000 |
| Total | $540,000 |
Pascoe received $450K in salary, accounting for 83% of the total pay in 2020.
Pascoe also received $90K in non-equity incentive plan.
Rankings
In 2020, Richard W. Pascoe's compensation ranked 10,816th out of 13,090 executives tracked by ExecPay. In other words, Pascoe earned more than 17.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,816 out of 13,090 | 17th |
Division Manufacturing | 4,619 out of 5,620 | 18th |
Major group Chemicals And Allied Products | 1,916 out of 2,253 | 15th |
Industry group Drugs | 1,680 out of 1,953 | 14th |
Industry Pharmaceutical Preparations | 1,240 out of 1,458 | 15th |
Source: SEC filing on April 15, 2021.
Pascoe's colleagues
We found three more compensation records of executives who worked with Richard W. Pascoe at Conatus Pharmaceuticals in 2020.